GlassScriptPhysician profile
Heather M Padgett
NPI 1093270357
$1,197.12
in general payments reported to CMS, 2019-2025
20 companies · $371 in 2025
The $371 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $381 · 2022: $16.04 · 2023: $152 · 2024: $277 · 2025: $371.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $800.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $196.69 | 2021-2025 | Repatha, Otezla |
| Exact Sciences Corporation | $189.54 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Lilly USA, LLC | $139.06 | 2021-2025 | Mounjaro, Zepbound |
| Pfizer INC. | $111.91 | 2021-2025 | |
| Abbvie INC. | $96.71 | 2021-2025 | |
| Organogenesis INC. | $83.33 | 2024 | |
| Glaxosmithkline, LLC. | $67.86 | 2024-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $51.31 | 2021-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $44.08 | 2025 | Airsupra |
| Takeda Pharmaceuticals U.S.A., INC. | $38.64 | 2025 | Gammagard |
| Novo Nordisk INC | $30.36 | 2021-2025 | |
| Medtronic, INC. | $23.54 | 2024 | Intellis Adaptivestim |
| Si-Bone, INC. | $23.13 | 2025 | |
| Lundbeck LLC | $18.75 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $16.33 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $16.04 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $15.50 | 2021 | |
| Shockwave Medical, INC | $14.37 | 2025 | |
| Merck Sharp & Dohme LLC | $13.39 | 2021 | |
| Neuronetics, INC. | $6.58 | 2025 | Neurostar Tms Therapy System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Padgett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.